Clinical Data Strength Leverage Proove Genomics’ extensive clinical data bank with 153,000 pain patients and 28 billion data points to position advanced analytics and predictive diagnostics as a differentiator for payer partnerships, hospitals, and large clinics seeking data-driven pain management and personalized treatment.

CLIA Certified Advantage Highlight the in-house CLIA-certified laboratory capabilities to enterprise buyers in need of compliant, high-quality laboratory testing services, enabling scalable contract testing, faster turnaround times, and robust quality controls for clinical trial support and standard care pathways.

Geographic Expansion Target expansion into southern California, Baltimore-Washington, and Salt Lake City markets as growth opportunities for regional hospital systems, pain clinics, and specialty centers seeking locally accessible testing, partnerships, and potential regional data collaborations.

Tech-Driven Solutions Promote the company’s use of advanced IT and mathematical algorithms, including PWA based interfaces and modern web tech stack, to emphasize seamless integration with healthcare IT ecosystems, EHR interoperability, and scalable analytics platforms for embedded decision support.

Strategic Collaborations Explore partnerships with leading medical societies, research networks, and pharmaceutical/biotech developers to co-develop predictive tools, expand evidence generation, and create joint offerings around precision medicine, pain management, and outcome-based reimbursement pilots.